Supplementary Figure S2 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
Aina Oliver-Caldes,Marta Español-Rego,Aintzane Zabaleta,Verónica González-Calle, Sergio Navarro-Velázquez,Susana Inogés,Ascensión López-Díaz de Cerio,Valentín Cabañas,Nieves López-Muñoz,Paula Rodríguez-Otero,Juan Luis Reguera,David F. Moreno,Nuria Martínez-Cibrian,Lucía López-Corral,Lorena Pérez-Amill,Beatriz Martin-Antonio,Laura Rosiñol,Joan Cid,Natalia Tovar,Joaquín Sáez-Peñataro,Miriam López-Parra,Eulalia Olesti,Elena Guillén,Sara Varea,Luis Gerardo Rodríguez-Lobato,Anthony M. Battram,Marta Sonia González,Andrés Sánchez-Salinas, Azucena González-Navarro,Valentín Ortiz-Maldonado, Julio Delgado, Felipe Prósper,Manel Juan, Joaquín Martínez-López,José M. Moraleda,Maria Victoria Mateos,Álvaro Urbano-Ispizua, Bruno Paiva,Mariona Pascal,Carlos Fernández de Larrea crossref（2024）
Abstract
Figure 2. PD-1 and TIGIT expression over time in two patients with available bone marrow samples until withdrawal of the study
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
